ID   TTK_HUMAN               Reviewed;         857 AA.
AC   P33981; B2RDW2; Q15272; Q5TCS0; Q9BW51; Q9NTM0;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   13-NOV-2007, sequence version 2.
DT   02-NOV-2010, entry version 110.
DE   RecName: Full=Dual specificity protein kinase TTK;
DE            EC=2.7.12.1;
DE   AltName: Full=Phosphotyrosine picked threonine-protein kinase;
DE            Short=PYT;
GN   Name=TTK; Synonyms=MPS1, MPS1L1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   MEDLINE=92348472; PubMed=1639825;
RA   Mills G.B., Schmandt R., McGill M., Amendola A., Hill M., Jacobs K.,
RA   May C., Rodricks A.-M., Campbell S., Hogg D.;
RT   "Expression of TTK, a novel human protein kinase, is associated with
RT   cell proliferation.";
RL   J. Biol. Chem. 267:16000-16006(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   MEDLINE=22935763; PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 504-802, AND CHARACTERIZATION.
RX   MEDLINE=93149596; PubMed=7678926;
RA   Lindberg R.A., Fischer W.H., Hunter T.;
RT   "Characterization of a human protein threonine kinase isolated by
RT   screening an expression library with antibodies to phosphotyrosine.";
RL   Oncogene 8:351-359(1993).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 525-792.
RX   MEDLINE=92065863; PubMed=1956325; DOI=10.1016/0076-6879(91)00126-H;
RA   Hanks S.K., Quinn A.M.;
RT   "Protein kinase catalytic domain sequence database: identification of
RT   conserved features of primary structure and classification of family
RT   members.";
RL   Methods Enzymol. 200:38-62(1991).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-821 AND SER-824, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.-R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa
RT   cells and high confident phosphopeptide identification by cross-
RT   validation of MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-436, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=19007248; DOI=10.1021/ac801708p;
RA   Wang B., Malik R., Nigg E.A., Korner R.;
RT   "Evaluation of the low-specificity protease elastase for large-scale
RT   phosphoproteome analysis.";
RL   Anal. Chem. 80:9526-9533(2008).
RN   [10]
RP   FUNCTION, AND MUTAGENESIS OF ASP-664.
RX   PubMed=18243099; DOI=10.1016/j.cell.2007.11.046;
RA   Jelluma N., Brenkman A.B., van den Broek N.J., Cruijsen C.W.A.,
RA   van Osch M.H.J., Lens S.M.A., Medema R.H., Kops G.J.P.L.;
RT   "Mps1 phosphorylates Borealin to control Aurora B activity and
RT   chromosome alignment.";
RL   Cell 132:233-246(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; THR-33; SER-37;
RP   SER-80; SER-281; SER-317; SER-393; SER-436 AND SER-821, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-33; SER-281; SER-321;
RP   SER-393 AND SER-821, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-281 AND SER-821, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-3; SER-7; THR-33;
RP   SER-49; SER-80; SER-281; SER-317; SER-321; SER-431; SER-436; THR-453;
RP   SER-455 AND SER-821, AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-216 AND SER-218, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [17]
RP   X-RAY CRYSTALLOGRAPHY (2.88 ANGSTROMS) OF 510-857 OF APOPROTEIN AND IN
RP   COMPLEX WITH SP600125, AND MUTAGENESIS OF ASP-664 AND THR-686.
RX   PubMed=18480048; DOI=10.1074/jbc.M803026200;
RA   Chu M.L.H., Chavas L.M.G., Douglas K.T., Eyers P.A., Tabernero L.;
RT   "Crystal structure of the catalytic domain of the mitotic checkpoint
RT   kinase Mps1 in complex with SP600125.";
RL   J. Biol. Chem. 283:21495-21500(2008).
RN   [18]
RP   X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 515-857.
RX   PubMed=19120698; DOI=10.1111/j.1582-4934.2008.00605.x;
RA   Wang W., Yang Y., Gao Y., Xu Q., Wang F., Zhu S., Old W., Resing K.,
RA   Ahn N., Lei M., Liu X.;
RT   "Structural and mechanistic insights into Mps1 kinase activation.";
RL   J. Cell. Mol. Med. 13:1679-1694(2009).
CC   -!- FUNCTION: Phosphorylates proteins on serine, threonine, and
CC       tyrosine. Probably associated with cell proliferation. Essential
CC       for chromosome alignment by enhancing AURKB activity (via direct
CC       CDCA8 phosphorylation) at the centromere, and for the mitotic
CC       checkpoint.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC   -!- ENZYME REGULATION: Inhibited by the ATP-competitive kinase
CC       inhibitor, SP600125.
CC   -!- INTERACTION:
CC       Self; NbExp=1; IntAct=EBI-1645856, EBI-1645856;
CC       Q53HL2:CDCA8; NbExp=1; IntAct=EBI-1645856, EBI-979174;
CC   -!- TISSUE SPECIFICITY: Present in rapidly proliferating cell lines.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Ser/Thr
CC       protein kinase family.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA61239.1; Type=Erroneous initiation;
CC       Sequence=CAB87580.1; Type=Erroneous initiation;
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; M86699; AAA61239.1; ALT_INIT; mRNA.
DR   EMBL; AK315696; BAG38059.1; -; mRNA.
DR   EMBL; AL133475; CAB87580.1; ALT_INIT; Genomic_DNA.
DR   EMBL; CH471051; EAW48699.1; -; Genomic_DNA.
DR   EMBL; BC000633; AAH00633.1; -; mRNA.
DR   EMBL; BC032858; AAH32858.1; -; mRNA.
DR   EMBL; X70500; CAA49912.1; -; mRNA.
DR   IPI; IPI00151170; -.
DR   PIR; A42861; A42861.
DR   RefSeq; NP_003309.2; -.
DR   UniGene; Hs.169840; -.
DR   PDB; 2ZMC; X-ray; 3.14 A; A=510-857.
DR   PDB; 2ZMD; X-ray; 2.88 A; A=510-857.
DR   PDB; 3CEK; X-ray; 2.30 A; A=519-808.
DR   PDB; 3DBQ; X-ray; 2.70 A; A=515-857.
DR   PDB; 3GFW; X-ray; 2.74 A; A=519-808.
DR   PDB; 3H9F; X-ray; 2.60 A; A=519-808.
DR   PDB; 3HMN; X-ray; 2.70 A; A=510-809.
DR   PDB; 3HMO; X-ray; 2.40 A; A=510-809.
DR   PDB; 3HMP; X-ray; 2.30 A; A=510-809.
DR   PDBsum; 2ZMC; -.
DR   PDBsum; 2ZMD; -.
DR   PDBsum; 3CEK; -.
DR   PDBsum; 3DBQ; -.
DR   PDBsum; 3GFW; -.
DR   PDBsum; 3H9F; -.
DR   PDBsum; 3HMN; -.
DR   PDBsum; 3HMO; -.
DR   PDBsum; 3HMP; -.
DR   ProteinModelPortal; P33981; -.
DR   IntAct; P33981; 3.
DR   MINT; MINT-1203816; -.
DR   STRING; P33981; -.
DR   PhosphoSite; P33981; -.
DR   PRIDE; P33981; -.
DR   Ensembl; ENST00000230510; ENSP00000230510; ENSG00000112742.
DR   GeneID; 7272; -.
DR   UCSC; uc003pjc.1; human.
DR   CTD; 7272; -.
DR   GeneCards; GC06P080771; -.
DR   H-InvDB; HIX0006028; -.
DR   HGNC; HGNC:12401; TTK.
DR   HPA; CAB010166; -.
DR   HPA; CAB013229; -.
DR   HPA; HPA016834; -.
DR   MIM; 604092; gene.
DR   PharmGKB; PA37066; -.
DR   eggNOG; prNOG10039; -.
DR   HOGENOM; HBG715956; -.
DR   HOVERGEN; HBG001029; -.
DR   InParanoid; P33981; -.
DR   OMA; QFELSQG; -.
DR   PhylomeDB; P33981; -.
DR   BRENDA; 2.7.12.1; 247.
DR   NextBio; 28427; -.
DR   ArrayExpress; P33981; -.
DR   Bgee; P33981; -.
DR   CleanEx; HS_TTK; -.
DR   Genevestigator; P33981; -.
DR   GermOnline; ENSG00000112742; Homo sapiens.
DR   GO; GO:0005819; C:spindle; TAS:ProtInc.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0004674; F:protein serine/threonine kinase activity; TAS:ProtInc.
DR   GO; GO:0004713; F:protein tyrosine kinase activity; TAS:ProtInc.
DR   GO; GO:0007094; P:mitotic cell cycle spindle assembly checkpoint; TAS:ProtInc.
DR   GO; GO:0007052; P:mitotic spindle organization; TAS:ProtInc.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; TAS:ProtInc.
DR   GO; GO:0010862; P:positive regulation of pathway-restricted S...; TAS:BHF-UCL.
DR   GO; GO:0006468; P:protein amino acid phosphorylation; IEA:InterPro.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR017442; Se/Thr_prot_kinase-like_dom.
DR   InterPro; IPR008271; Ser/Thr_prot_kinase_AS.
DR   InterPro; IPR002290; Ser/Thr_prot_kinase_dom.
DR   InterPro; IPR011990; TPR-like_helical.
DR   Gene3D; G3DSA:1.25.40.10; TPR-like_helical; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; ATP-binding; Complete proteome; Kinase;
KW   Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Serine/threonine-protein kinase; Transferase; Tyrosine-protein kinase.
FT   CHAIN         1    857       Dual specificity protein kinase TTK.
FT                                /FTId=PRO_0000086774.
FT   DOMAIN      525    791       Protein kinase.
FT   NP_BIND     531    539       ATP (By similarity).
FT   ACT_SITE    647    647       Proton acceptor (By similarity).
FT   BINDING     553    553       ATP (By similarity).
FT   MOD_RES       3      3       Phosphoserine.
FT   MOD_RES       7      7       Phosphoserine.
FT   MOD_RES      33     33       Phosphothreonine.
FT   MOD_RES      37     37       Phosphoserine.
FT   MOD_RES      49     49       Phosphoserine.
FT   MOD_RES      80     80       Phosphoserine.
FT   MOD_RES     216    216       Phosphoserine.
FT   MOD_RES     218    218       Phosphoserine.
FT   MOD_RES     281    281       Phosphoserine.
FT   MOD_RES     317    317       Phosphoserine.
FT   MOD_RES     321    321       Phosphoserine.
FT   MOD_RES     393    393       Phosphoserine.
FT   MOD_RES     431    431       Phosphoserine.
FT   MOD_RES     436    436       Phosphoserine.
FT   MOD_RES     453    453       Phosphothreonine.
FT   MOD_RES     455    455       Phosphoserine.
FT   MOD_RES     821    821       Phosphoserine.
FT   MOD_RES     824    824       Phosphoserine.
FT   VARIANT      97     97       A -> V (in dbSNP:rs2230513).
FT                                /FTId=VAR_037141.
FT   VARIANT     758    758       D -> N (in dbSNP:rs2230512).
FT                                /FTId=VAR_037142.
FT   MUTAGEN     664    664       D->A: Loss of kinase activity.
FT   MUTAGEN     686    686       T->A: Loss of kinase activity.
FT   CONFLICT    389    389       S -> A (in Ref. 1; AAA61239).
FT   CONFLICT    768    768       L -> V (in Ref. 6; CAA49912 and 7).
FT   STRAND      524    530
FT   STRAND      537    543
FT   STRAND      549    556
FT   HELIX       562    578
FT   HELIX       579    581
FT   STRAND      588    593
FT   STRAND      595    602
FT   HELIX       609    615
FT   HELIX       621    640
FT   HELIX       650    652
FT   STRAND      653    655
FT   STRAND      660    662
FT   HELIX       687    689
FT   HELIX       692    695
FT   HELIX       713    719
FT   HELIX       723    728
FT   TURN        733    736
FT   HELIX       740    748
FT   HELIX       762    771
FT   TURN        776    778
FT   HELIX       782    786
FT   HELIX       789    792
SQ   SEQUENCE   857 AA;  97072 MW;  51F40A3CD1677AC5 CRC64;
     MESEDLSGRE LTIDSIMNKV RDIKNKFKNE DLTDELSLNK ISADTTDNSG TVNQIMMMAN
     NPEDWLSLLL KLEKNSVPLS DALLNKLIGR YSQAIEALPP DKYGQNESFA RIQVRFAELK
     AIQEPDDARD YFQMARANCK KFAFVHISFA QFELSQGNVK KSKQLLQKAV ERGAVPLEML
     EIALRNLNLQ KKQLLSEEEK KNLSASTVLT AQESFSGSLG HLQNRNNSCD SRGQTTKARF
     LYGENMPPQD AEIGYRNSLR QTNKTKQSCP FGRVPVNLLN SPDCDVKTDD SVVPCFMKRQ
     TSRSECRDLV VPGSKPSGND SCELRNLKSV QNSHFKEPLV SDEKSSELII TDSITLKNKT
     ESSLLAKLEE TKEYQEPEVP ESNQKQWQSK RKSECINQNP AASSNHWQIP ELARKVNTEQ
     KHTTFEQPVF SVSKQSPPIS TSKWFDPKSI CKTPSSNTLD DYMSCFRTPV VKNDFPPACQ
     LSTPYGQPAC FQQQQHQILA TPLQNLQVLA SSSANECISV KGRIYSILKQ IGSGGSSKVF
     QVLNEKKQIY AIKYVNLEEA DNQTLDSYRN EIAYLNKLQQ HSDKIIRLYD YEITDQYIYM
     VMECGNIDLN SWLKKKKSID PWERKSYWKN MLEAVHTIHQ HGIVHSDLKP ANFLIVDGML
     KLIDFGIANQ MQPDTTSVVK DSQVGTVNYM PPEAIKDMSS SRENGKSKSK ISPKSDVWSL
     GCILYYMTYG KTPFQQIINQ ISKLHAIIDP NHEIEFPDIP EKDLQDVLKC CLKRDPKQRI
     SIPELLAHPY VQIQTHPVNQ MAKGTTEEMK YVLGQLVGLN SPNSILKAAK TLYEHYSGGE
     SHNSSSSKTF EKKRGKK
//
